Related posts
Fed jitters pressure marketsThis summary was created by AI, based on 3 opinions in the last 12 months.
Centene (CNC-N) is a healthcare provider for under-insured families and military personnel in the US. The company is experiencing growth in cash reserves, while actively retiring debt and buying back shares. With a low price-to-earnings ratio and strong return on equity, Centene is seen as a top pick with significant upside potential. The stock is seen as undervalued and offers a good buying opportunity, with analysts' price targets indicating room for growth.
About as cheap as it's been in the last 5 years at 1.25x book. FMV is 93% above current price. Earnings and FMV continue to rise. A good buying opportunity.
Centene is a American stock, trading under the symbol CNC-N on the New York Stock Exchange (CNC). It is usually referred to as NYSE:CNC or CNC-N
In the last year, 1 stock analyst published opinions about CNC-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Centene.
Centene was recommended as a Top Pick by on . Read the latest stock experts ratings for Centene.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered Centene In the last year. It is a trending stock that is worth watching.
On 2024-03-28, Centene (CNC-N) stock closed at a price of $78.505.
We reiterate CNC, a provider of healthcare to under-insured families and military personnel in the US as a TOP PICK. It continues to build cash reserves, while retiring debt and buying back shares. It trades at 16x earnings, under 2x book and supports a 10% ROE. We recommend trailing up the stop (from $63) to $72, looking to achieve $90 — upside potential of 16%. Yield 0%
(Analysts’ price target is $89.64)